Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
Clinical trial NCT01578967 · COMPLETED
Trial details
- NCT number
- NCT01578967
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-08-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.